Navigation Links
Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010
Date:2/10/2011

antibody library materials ($6.0M).

(8) To exclude imputed interest expense associated with convertible debt.

(9) In 2010, to exclude the change in fair value of our investment in Mesoblast Limited ($12.0M), offset by the change in fair value of our investment in ChemGenex Pharmaceuticals Limited ($4.1M).

(10) In 2010, to exclude the following:

  • $2.0M gain on foreign exchange of Australian Dollar acquisition funds;
  • $6.5M proceeds received in a settlement
  • $9.1M net loss on foreign exchange derivative instruments related to the acquisition of Mepha GmbH; and
  • $2.5M loss on foreign exchange of Swiss Franc acquisition funds.

  • In 2009, to exclude the following gains and losses related to the acquisition of Arana Therapeutics Limited:

  • $6.6M gain on pre-bid Arana Therapeutics Limited holding;
  • $2.8M loss on contingent consideration (90% ownership incentive payment);
  • $10.0M gain on excess of net assets over consideration;
  • $19.0M gain on foreign exchange derivative instruments;  
  • $5.6M gain on foreign exchange of Australian Dollar acquisition funds; and
  • $1.6M gain on dividend income related to our initial purchase of Arana Therapeutics Limited shares.

  • (11) In 2009, to exclude the portion of non-cash charges related to our acquisition of Arana Therapeutics Limited that are reflected in (10) above but do not affect net income because they are attributed to noncontrolling interests.

    (12) To reflect the tax effect of pre-tax adjustments at applicable tax rates and certain other tax adjustments primarily related to; changes in valuation allowances and other changes in tax assets and liabilities.

    CEPHALON, INC. AND SUBSIDIARIESCONSOLIDATED SALES DETAIL(In thousands)(Unaudited)Three Months Ended%December 31Increase20102009(Decrease)United StatesEuropeTotalUnited StatesEuropeTotalUnited StatesEuropeTotalSales:CNSProprietary CNSPROVIGIL$
    '/>"/>

    SOURCE Cephalon, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
    2. ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology
    3. Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
    4. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
    5. Cephalon to Webcast Investor Day
    6. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
    7. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
    8. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
    9. Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
    10. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
    11. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/15/2014)... Sept. 15, 2014 /CNW/ - Health Minister Rona Ambrose ... make available for donation over $2.5 million in personal protective ... in the global response to the Ebola outbreak in ... reported a shortage of equipment in the affected countries and ... front-line workers in the affected countries. Personal ...
    (Date:9/15/2014)... FRANCISCO , Sept. 15, 2014 ... studies presented at the American Society for Radiation ... its Decipher® Prostate Cancer Classifier, a genomic test ... influence treatment decisions and improve patient outcomes for ... These presentations follow a recently published study that ...
    (Date:9/15/2014)... , Sept. 15, 2014  Alere Inc. (NYSE: ... in infectious disease, toxicology, cardiology and diabetes products and ... led by former CEO Ron Zwanziger , filed ... and subsequently sent a letter to Gregg J. ... of due diligence in an effort to secure financing ...
    Breaking Medicine Technology:Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 3Alere Responds To Letter From Former Executives 2
    (Date:9/15/2014)... 16, 2014)The Global Health Innovative Technology Fund (GHIT ... bringing Japanese know-how and investment to the global ... investments totaling US$15.3 million to speed the development ... insect-borne diseasesmalaria, dengue and Chagas disease. The announcement ... investments since November 2013totaling $33.5 millionaimed at diseases ...
    (Date:9/15/2014)... The Best Hospitals Honor Roll ... seven hospitals using OnBase as their enterprise content ... were ranked at the top of the list, earning ... nearly 5,000 medical centers across the country with the ... highest in at least six of the sixteen specialties ...
    (Date:9/15/2014)... Randy Dotinga ... News) -- Patients prescribed cholesterol-lowering drugs are more likely ... the medications are cheaper generic brands, new research suggests. ... statins. Well-known brands include Crestor, Zocor and Lipitor. Generic ... lower the risk of heart problems due to clogged ...
    (Date:9/15/2014)... FL (PRWEB) September 15, 2014 The ... away from putting low-level offenders in jail and prison ... Group sees this shift as a positive change. , ... prescription drug and heroin abuse. According to an ... parties are calling for a shift away from using ...
    (Date:9/15/2014)... Dennis Thompson HealthDay ... -- The severe respiratory virus believed to have sickened ... has now spread to the Northeast, health officials report. ... on Friday more than a dozen cases of infection ... children with asthma. And on Saturday, the Connecticut ...
    Breaking Medicine News(10 mins):Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 2Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 3Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 4Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 5Health News:Seven of Top Ten Hospitals in the U.S. Leverage OnBase by Hyland ECM Solution 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 3Health News:White House Shifts Policy on Drugs 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3
    ... NEW YORK (Nov. 22 2009) -- Physician-scientists from Weill Cornell ... to be a powerful target for the treatment of non-Hodgkin,s ... blood cells. By exploiting this mechanism, researchers have been able ... animal models. Promising results have led to the design ...
    ... ... can be both fun and joyous. It can also be stressful and tiring ... foods -- factors that can, over time, increase your risk of cancer. That,s ... 10 Food Tips that can help ensure a happier, more healthful holiday season, ...
    ... , WASHINGTON, Nov. 21 DNC Chairman ... to begin full debate of health insurance reform legislation. ... Senate took another historic step on the road to enacting ... will now have an opportunity to debate the health reform ...
    ... , , Association Discusses Key ... Reform , ST. CHARLES, Ill., Nov. 21 ... Affordable Health Care for America Act (H.R. 3962), and the ... decisive steps to fix our nation,s broken health care system. ...
    ... , ... addictive game, SplitWords, is now available on the iPhone and iPod Touch. , ... Mountain View, CA (PRWEB) November 21, 2009 ... iPod Touch. Split Words is designed to help banish that ,tip of the tongue, syndrome ...
    ... , Pioneering Neurologist Closer to Understanding ... Dr. Jeremy Schmahmann, Professor of Neurology at Harvard Medical ... Boston, on Thursday, November 19, presented his laboratory,s research ... the launch of the MINDlink Foundation. , Dr. Schmahmann ...
    Cached Medicine News:Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: